Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Neuropsychopharmacology (8)
Nature Medicine (1)
Scientific Reports (1)
NPP—Digital Psychiatry and Neuroscience (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (9)
Research Highlights (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cardiology
Chemical biology
Diseases
Drug discovery
Health care
Medical research
Neuroscience
Psychology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–11 of 11 results

Advanced filters: Author: Ziva D Cooper Clear advanced filters

Signaling-specific inhibition of the CB₁ receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

The signaling-specific inhibitor AEF0117 selectively inhibits CB₁ activation by THC and reduces self-administration and subjective effects of cannabis in clinical trials, making it a potential treatment for cannabis use disorder.

Margaret Haney
Monique Vallée
Pier Vincenzo Piazza
ResearchOpen Access08 Jun 2023
Nature Medicine

Volume: 29, P: 1487-1499
Mobile EEG examination of putative biomarkers of mental health in individuals that use cannabis

Conor H. Murray
Kaihan Danesh
Ziva D. Cooper
ResearchOpen Access03 Jul 2025
NPP—Digital Psychiatry and Neuroscience

Volume: 3, P: 1-8
Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial

Carrie Cuttler
Amanda Stueber
Ethan Russo
ResearchOpen Access13 Jul 2024
Scientific Reports

Volume: 14, P: 1-14
Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers

Margaret Haney
Divya Ramesh
Ziva D Cooper
Research16 Apr 2015
Neuropsychopharmacology

Volume: 40, P: 2489-2498
Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse

Margaret Haney
Ziva D Cooper
Richard W Foltin
Research26 Feb 2013
Neuropsychopharmacology

Volume: 38, P: 1557-1565
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective

Ziva D Cooper
Rebecca M Craft
Reviews17 Jul 2017
Neuropsychopharmacology

Volume: 43, P: 34-51
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis

Margaret Haney
Robert J Malcolm
Sharon L Walsh
Research28 Dec 2015
Neuropsychopharmacology

Volume: 41, P: 1974-1982
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability

Ziva D. Cooper
Gillinder Bedi
Margaret Haney
Research05 Feb 2018
Neuropsychopharmacology

Volume: 43, P: 2046-2055
Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers

Sandra D Comer
Shanthi Mogali
Richard W Foltin
Research05 Jun 2013
Neuropsychopharmacology

Volume: 38, P: 2427-2438
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers

Ziva D Cooper
Sandra D Comer
Margaret Haney
Research22 Apr 2013
Neuropsychopharmacology

Volume: 38, P: 1984-1992
Controlled human drug administration studies are necessary to define the THC-sparing effects of CBD and other cannabis constituents

Elisa Pabon
Ziva D. Cooper
Research HighlightsOpen Access01 Feb 2023
Neuropsychopharmacology

Volume: 48, P: 850-851